Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nippon Kayaku Co., Ltd. (4272.T)
Tokyo, JP
Nippon Kayaku Co., Ltd., along with its subsidiary companies, is a global enterprise based in Tokyo, Japan. Established in 1916 and originally known as Nihon Kayaku Seizou Co., Ltd. until its rebranding in 1945, the company specializes in the development, manufacturing, and sale of a diverse range of products across several key sectors. Its Functional and Chemical Business segment supplies advanced materials, including epoxy and UV-curable resins, sealants for LCD and LED screens, maleimide resins, photoresists, and insulating materials crucial for micro-electromechanical systems (MEMS), as well as various cleaning agents. This division also produces a variety of colorants, such as inkjet pigments, textile and paper dyes, and materials used in thermal paper. Furthermore, it manufactures catalysts for acrylic and methacrylic acid production, alongside optical and analytical components like polarizing films, inorganic polarizers, parts for liquid crystal displays and projectors, and components for X-ray analysis. The Pharmaceuticals Business segment focuses on healthcare, offering a portfolio that includes anti-cancer and cancer-related medications, biosimilars, generic drugs, interventional radiology products, and cardiovascular treatments. It also provides bulk pharmaceuticals, drug intermediates, and cancer diagnostic agents, notably featuring GlycoMark, a specialized marker for managing blood sugar levels in diabetes. In the Safety Systems Business segment, the company develops and produces critical automotive safety components, such as airbag inflators, micro gas generators for seatbelt pretensioners, and squibs. Finally, the Agrochemicals Business segment provides solutions for agricultural and public health needs, encompassing agricultural insecticides, herbicides, soil fumigants, and products designed for insanitary pest control. Beyond these core industrial activities, Nippon Kayaku Co., Ltd. also manages real estate leasing services.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.59% | +21.27% | +19.90% | +14.07% | +42.98% | +26.47% | +54.81% | +68.04% | +113.90% | +107.22% | +403.32% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+8.7% ★ Q1'26: +23.1% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+50.4% ★ Q1'26: +86.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+2.8% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+9.3% ★ Q1'26: +9.1% (vs Q1'25)
-
ROIC Chemicals: +3.4%+6.0% ★ Q1'26: +7.1% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-6.4% ★ Q1'26: -6.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.29× ★ Q1'26: 1.19× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
161.86B
est: 165.15B (-2.0%)
|
162.92B
est: 165.47B (-1.5%)
|
159.11B
est: 160.15B (-0.6%)
|
167.88B
est: 169.40B (-0.9%)
|
172.64B
est: 174.90B (-1.3%)
|
175.13B
est: 183.70B (-4.7%)
|
173.38B
est: 194.00B (-10.6%)
|
201.79B
est: 202.50B (-0.4%)
|
222.58B
est: 224.00B (-0.6%)
|
239.75B
239.75B – 239.75B
+7.0% YoY
|
248.50B
248.50B – 248.50B
+3.6% YoY
|
258.50B
258.50B – 258.50B
+4.0% YoY
|
| EBITDA |
33.47B
est: 27.52B (+21.6%)
|
33.12B
est: 27.57B (+20.1%)
|
31.13B
est: 26.69B (+16.6%)
|
34.41B
est: 28.23B (+21.9%)
|
32.13B
est: 29.15B (+10.2%)
|
30.07B
est: 30.61B (-1.8%)
|
28.67B
est: 32.33B (-11.3%)
|
21.74B
est: 32.33B (-32.8%)
|
34.48B
est: 35.77B (-3.6%)
|
38.28B
38.28B – 38.28B
+7.0% YoY
|
39.68B
39.68B – 39.68B
+3.6% YoY
|
41.28B
41.28B – 41.28B
+4.0% YoY
|
| EBIT |
22.25B
est: 15.62B (+42.4%)
|
21.67B
est: 15.65B (+38.5%)
|
19.61B
est: 15.14B (+29.5%)
|
22.20B
est: 16.02B (+38.6%)
|
19.94B
est: 16.54B (+20.6%)
|
17.49B
est: 17.37B (+0.7%)
|
15.19B
est: 18.34B (-17.2%)
|
7.34B
est: 17.74B (-58.6%)
|
20.40B
est: 19.62B (+4.0%)
|
21.00B
21.00B – 21.00B
+7.0% YoY
|
21.77B
21.77B – 21.77B
+3.6% YoY
|
22.64B
22.64B – 22.64B
+4.0% YoY
|
| Net Income |
15.65B
est: 14.69B (+6.5%)
|
17.29B
est: 14.20B (+21.7%)
|
15.64B
est: 13.81B (+13.2%)
|
15.49B
est: 15.10B (+2.6%)
|
14.85B
est: 13.59B (+9.3%)
|
12.82B
est: 14.82B (-13.5%)
|
12.57B
est: 16.22B (-22.5%)
|
4.11B
est: 5.72B (-28.1%)
|
17.51B
est: 18.18B (-3.7%)
|
23.25B
23.25B – 23.25B
+27.9% YoY
|
23.13B
23.13B – 23.13B
-0.5% YoY
|
26.48B
26.48B – 26.48B
+14.5% YoY
|
| SGA |
31.11B
est: 36.05B (-13.7%)
|
30.75B
est: 36.12B (-14.9%)
|
29.60B
est: 34.96B (-15.3%)
|
30.33B
est: 36.97B (-18.0%)
|
30.27B
est: 38.18B (-20.7%)
|
28.93B
est: 40.10B (-27.8%)
|
27.79B
est: 42.34B (-34.4%)
|
33.17B
est: 32.20B (+3.0%)
|
35.16B
est: 35.62B (-1.3%)
|
38.12B
38.12B – 38.12B
+7.0% YoY
|
39.51B
39.51B – 39.51B
+3.6% YoY
|
41.10B
41.10B – 41.10B
+4.0% YoY
|
| EPS |
86.38
est: 89.95 (-4.0%)
|
96.08
est: 86.95 (+10.5%)
|
90.23
est: 84.56 (+6.7%)
|
89.45
est: 92.40 (-3.2%)
|
85.77
est: 83.20 (+3.1%)
|
74.25
est: 90.70 (-18.1%)
|
73.62
est: 99.30 (-25.9%)
|
24.80
est: 35.00 (-29.1%)
|
107.17
est: 111.30 (-3.7%)
|
142.30
142.30 – 142.30
+27.9% YoY
|
141.60
141.60 – 141.60
-0.5% YoY
|
162.10
162.10 – 162.10
+14.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Japan Opportunities Fund OPPJ | 0.95% | 2.68M | 0.58% |
| 2 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.38% | 1.48M | 0.58% |
| 3 | WisdomTree International SmallCap Dividend Fund DLS | 0.14% | 1.47M | 0.58% |
| 4 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.13% | 573.9K | 0.48% |
| 5 | iShares MSCI Japan Small-Cap ETF SCJ | 0.11% | 295.4K | 0.50% |
| 6 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.11% | 605.4K | 0.58% |
| 7 | Xtrackers FTSE Developed ex US Multifactor ETF DEEF | 0.11% | 57.9K | 0.24% |
| 8 | FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund TLTD | 0.10% | 671.8K | 0.41% |
| 9 | WisdomTree International High Dividend Fund DTH | 0.09% | 543.1K | 0.58% |
| 10 | WisdomTree Japan Equity UCITS ETF DXJ.L | 0.09% | 696.7K | 0.48% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hideyuki Yuya | MD & Head of Polatechno Group | — | — |
| Hiroshi Shimada | Senior MD, Head of Pharmaceuticals Group & Director | — | — |
| Ichio Kohinata | General Manager of Legal Affairs Division | — | — |
| Makoto Takeda | MD of Human Resource & Director | — | — |
| Seiichiro Kodama | Head of Agrochemicals Group of Life Science Business Unit | — | — |
| Shigehide Kagaya | Head of Catalysts Group, Fine Chemicals Business Unit | — | — |
| Shigeyuki Kawamura | President, Chief Executive Officer & Director | — | male |
| Shinji Inoue | Senior Executive Officer of planning, Corporation Communication & Accounting and Director | — | — |
| Tsutomu Kawamura | General Manager of Finance & Accounting Division | — | male |
| Yasuhito Kato | MD of Technology & Director | — | — |
| Yoshiki Akatani | Managing Director of Fine Chemicals Business Area | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4272.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
